Clinical trial
Prevalence of Cognitive Disorders in Newly Diagnosed Epilepsy
NCT04727931 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Cognitive Disorders in Newly Diagnosed Epilepsy
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 17, 2021
- Completion date
- February 1, 2026
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognition, epilepsy